These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11319913)

  • 21. Expression of the human glucocerebrosidase and arylsulfatase A genes in murine and patient primary fibroblasts transduced by an adeno-associated virus vector.
    Wei JF; Wei FS; Samulski RJ; Barranger JA
    Gene Ther; 1994 Jul; 1(4):261-8. PubMed ID: 7584090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
    Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
    Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.
    Bakowska JC; Di Maria MV; Camp SM; Wang Y; Allen PD; Breakefield XO
    Gene Ther; 2003 Sep; 10(19):1691-702. PubMed ID: 12923568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene targeting in vivo by adeno-associated virus vectors.
    Miller DG; Wang PR; Petek LM; Hirata RK; Sands MS; Russell DW
    Nat Biotechnol; 2006 Aug; 24(8):1022-6. PubMed ID: 16878127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene targeting in human pluripotent stem cells with adeno-associated virus vectors.
    Mitsui K; Suzuki K; Aizawa E; Kawase E; Suemori H; Nakatsuji N; Mitani K
    Biochem Biophys Res Commun; 2009 Oct; 388(4):711-7. PubMed ID: 19695233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.
    Brommel CM; Cooney AL; Sinn PL
    Hum Gene Ther; 2020 Sep; 31(17-18):985-995. PubMed ID: 32718227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stable transduction of large DNA by high-capacity adeno-associated virus/adenovirus hybrid vectors.
    Gonçalves MA; van der Velde I; Knaän-Shanzer S; Valerio D; de Vries AA
    Virology; 2004 Apr; 321(2):287-96. PubMed ID: 15051388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.
    Halbert CL; Allen JM; Miller AD
    Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
    Flannery JG; Visel M
    Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AAV-mediated gene targeting methods for human cells.
    Khan IF; Hirata RK; Russell DW
    Nat Protoc; 2011 Apr; 6(4):482-501. PubMed ID: 21455185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types.
    Lebkowski JS; McNally MM; Okarma TB; Lerch LB
    Mol Cell Biol; 1988 Oct; 8(10):3988-96. PubMed ID: 2847025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus vectors integrate at chromosome breakage sites.
    Miller DG; Petek LM; Russell DW
    Nat Genet; 2004 Jul; 36(7):767-73. PubMed ID: 15208627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospects and RISC score of viral gene therapy for sarcoma.
    Fruehauf S; Veldwijk MR; Zeller WJ; Laufs S
    Expert Opin Biol Ther; 2003 Dec; 3(8):1241-51. PubMed ID: 14640950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gene therapy using AAV (adeno-associated virus) vectors].
    Ozawa K
    Uirusu; 2003 Dec; 53(2):163-70. PubMed ID: 15080081
    [No Abstract]   [Full Text] [Related]  

  • 37. Trans-splicing vectors expand the packaging limits of adeno-associated virus for gene therapy applications.
    Duan D; Yue Y; Yan Z; Engelhardt JF
    Methods Mol Med; 2003; 76():287-307. PubMed ID: 12526170
    [No Abstract]   [Full Text] [Related]  

  • 38. Correction of chromosomal mutation and random integration in embryonic stem cells with helper-dependent adenoviral vectors.
    Ohbayashi F; Balamotis MA; Kishimoto A; Aizawa E; Diaz A; Hasty P; Graham FL; Caskey CT; Mitani K
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13628-33. PubMed ID: 16174752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Innovative vector design: cross-packaged, self-complementary and now trans-splicing AAV vectors.
    Byrne BJ
    Hum Gene Ther; 2009 Nov; 20(11):1224-5. PubMed ID: 20374097
    [No Abstract]   [Full Text] [Related]  

  • 40. A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair.
    Leclerc X; Danos O; Scherman D; Kichler A
    BMC Biotechnol; 2009 Apr; 9():35. PubMed ID: 19379497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.